MULINACCI, BARBARA

MULINACCI, BARBARA  

Scienze farmaceutiche (attivo dal 01/08/1980 al 31/12/2012)  

Mostra records
Risultati 1 - 20 di 22 (tempo di esecuzione: 0.017 secondi).
Titolo Data di pubblicazione Autore(i) File
A Glycopeptide-based Technique for Selective Antibodies Purification. 2007 E. Peroni; M. Tontini; B. Mulinacci; M. Chelli; P. Rovero; A.M. Papini.
A proteomic approach to characterize a native antigen involved in autoantibody response in Multiple Sclerosis by a structure-based designed glycopeptide. 2004 B. Mazzanti; M. Pazzagli; M.C. Alcaro; B. Mulinacci; E. Peroni; F. Nuti; G. Sabatino; M.C. Pozo-Carrero; A. Carotenuto; B. Bonetti; L. Battistini; D. Franciotta; S. Sotgiu; R. Lanzillo; M. Chelli; P. Rovero; F. Lolli; A. M. Papini
An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. 2005 F. LOLLI; MULINACCI B; CAROTENUTO A; BONETTI B; SABATINO G; MAZZANTI B; D'URSI AM; NOVELLINO E; PAZZAGLI M; LOVATO L; ALCARO MC; PERONI E; POZO-CARRERO MC; NUTI F; BATTISTINI L; BORSELLINO G; CHELLI M; ROVERO P; PAPINI AM.
Antigenic probes for autoantibody detection in Multiple Sclerosis: synthetic peptides versus recombinant proteins 2010 F. Gori; B. Mulinacci; L. Massai; F. Lolli; A.M. Papini; P. Rovero
Antigenic Probes for Autoantibody Detection in Multiple Sclerosis: Synthetic Peptides Versus Recombinant Proteins 2010 F. Gori; B. Mulinacci; L. Massai; F. Lolli; A.M. Papini; P. Rovero
Assessment of new 6Cl-HOBt based coupling reagents for peptide synthesis. Part 1: Coupling efficiency study 2003 G. SABATINO; B. MULINACCI; M. ALCARO; M. CHELLI; P. ROVERO; A.M. PAPINI
Beta-hairpin glycopeptides as mimetic autoantigens in Multiple Sclerosis 2004 B. Mulinacci; I. Paolini; A. Carotenuto; B. Mazzanti; M. Pazzagli; M. Chelli; F. Lolli; P. Rovero; A.M. Papini
Beta-Hairpin glycopeptides as mimetic autoantigens in multiple sclerosis 2005 B. Mulinacci; I. Paolini; A. Carotenuto; B. Mazzanti; M. Pazzagli; M. Chelli; F. Lolli; P. Rovero; A.M. Papini
CONFORMATION-ACTIVITY RELATIONSHIP OF DESIGNED GLYCOPEPTIDES AS SYNTHETIC PROBES FOR THE DETECTION OF AUTOANTIBODIES, BIOMARKERS OF MULTIPLE SCLEROSIS 2006 A. CAROTENUTO; A. D'URSI; B. MULINACCI; I. PAOLINI; F. LOLLI; A.M. PAPINI; E. NOVELLINO; P. ROVERO
Cross-reactivity studies of rMOG(ED) with synthetic putative autoantigens CSF114(Glc) and [N-31(Glc)]hMOG(30-50) in multiple sclerosis patients' sera. 2005 B. Mulinacci; C. Breithaupt; P.P. Pal; N. Budisa; M. Pazzagli; B. Mazzanti; P. Rovero; L. Moroder; A.M. Papini.
CROSS-REACTIVITY STUDIES OF RMOGED WITH SYNTHETIC PUTATIVE AUTOANTIGENS CSF114(GLC) AND [N31(GLC)]HMOG(30-50)IN MULTIPLE SCLEROSIS PATIENTS'SERA 2006 B. MULINACCI; M. PAZZAGLI; B. MAZZANTI; P. ROVERO; L. MORODER; A. PAPINI; C. BREITHAUPT; P. PRAJNA; B. NEDIJLKO
Identification of new autoantigens in Multiple Sclerosis by glycopeptide libraries 2004 M.C. Alcaro; E. Naldini; B. Mulinacci; B. Mazzanti; M. Pazzagli; F. Lolli; M. Chelli; P. Rovero; A.M. Papini
Identification of new autoantigens in Multiple Sclerosis by glycopeptide libraries 2005 M. ALCARO; B. MULINACCI; B. MAZZANTI; M. PAZZAGLI; E. PERONI; M. CHELLI; P. ROVERO; A. PAPINI; E. NALDINI
Improvement of autoantibody detection in autoimmune diseases by innovative solid-phase glycopeptide based technologies. 2006 F. Nuti; E. Peroni; E.S. Bulukin; B. Mulinacci; M. Chelli; P. Rovero; A.M. Papini
MS PepKit, the first diagnostic test based on CSF114(Glc) a glycopeptide to follow-up Multiple Sclerosis. 2003 A.M. Papini, B. Mulinacci, E. Peroni, F. Nuti, G. Sabatino, M.C. Pozo-Carrero, B. Mazzanti, M. Pazzagli, L. Massacesi, M. Chelli, P. Rovero, F. Lolli
MS PepKit: the first diagnostic test based on CSF114(Glc), a glycopeptide to follow-up Multiple Sclerosis. 2003 A. M. Papini; B. Mulinacci; E. Peroni; F. Nuti; G. Sabatino; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; L. Massacesi; M. Chelli; P. Rovero; F. Lolli
MS PepKit: The first diagnostic test to follow-up multiple sclerosis 2004 A.M. Papini; B. Mulinacci; A. Carotenuto; B. Bonetti; G. Sabatino; E. Peroni; F. Nuti; M.C. Alcaro; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; L. Massacesi; L. Battistini; M. Chelli; P. Rovero; F. Lolli;
Semi-synthesis of glucosylated recombinant MOG as auto-antigen in multiple sclerosis. 2007 B. Mulinacci; F. Gori; E. Bonchi; M. Chelli; F. Lolli; A.M. Papini; P. Rovero.
Small Focused Library of CSF114-type Glycopeptides For the Characterization of Autoantibody Recognition in Multiple Sclerosis 2004 F. Nuti; I. Paolini; B. Mulinacci; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; F. Lolli; M. Chelli; F.M. Cordero; A. Brandi; A.M. Papini
Structure-Activity Relationship Study of Glycopeptide Antigens Recognizing Specific Autoantibodies in Multiple Sclerosis 2004 B. Mulinacci; F. Nuti; G. Sabatino; M. Chelli; A. Carotenuto; P. Rovero; B. Mazzanti; M. Pazzagli; F. Lolli; A.M. Papini